Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Finance

Back for more

Tallying Vivo's recent exits as VC raises $428M for eighth fund

January 5, 2015 8:00 AM UTC

About three years after closing its last fund, Vivo Capital (formerly Vivo Ventures) has come back for more. The firm raised $428 million for an eighth fund, according to a December SEC filing.

Vivo invests primarily in U.S. therapeutics and medical device companies in late-stage development, and in revenue-generating healthcare companies in greater China, with some small investments in public therapeutics companies. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article